A Study to Determine the Absorption, Distribution, Metabolism, and Excretion of LBH589

Inclusion criteria * Histologically or cytologically confirmed cancer patients including solid tumors, lymphoma, or chronic hematological malignancies with progression on prior standard therapies. * Eastern Cooperative Oncology Group (ECOG) Performance Status of \< 2 * Normal renal and hepatic function Exclusion criteria * Patients with central nervous system (CNS) involvement or brain metastases * Patients who have received chemotherapy, any investigational drug, undergone major surgery, or received wide field radiotherapy less than 4 weeks ago * Patients with congenital long QT syndrome or uncontrolled hypertension * Patients with a myocardial infarction or unstable angina within 6 months * Congestive heart failure * Impairment of gastrointestinal (GI) function * Use of any anti-cancer therapy * Female patients who are pregnant or breast feeding Other protocol inclusion/exclusion criteria may apply.